The first Fate Therapeutics trade was made in Q1 2015.
Since then Jim Simons bought shares fourteen more times and sold shares on sixteen occasions. The investor completely sold their stake between Q1 2023 and Q4 2023.
Avg closing price
Price range
Sold -109 Thousand shares
Q4 2023
Avg closing price
$2.36
Price range
$1.65
-
$3.94
Sold 83.8% shares (-563 Thousand shares)
Q3 2023
Avg closing price
$3.31
Price range
$2.02
-
$5.04
Sold 49.6% shares (-661 Thousand shares)
Q2 2023
Avg closing price
$5.52
Price range
$4.76
-
$6.59
Sold 26.2% shares (-472 Thousand shares)
Q1 2023
Avg closing price
$6.03
Price range
$4.24
-
$11.12
Increased shares by 235.8% (+1.27 Million shares)
Q4 2022